Even Short Term Use of NSAID With Anticoagulant Ill Advised

This article originally appeared here.
Share this content:
Even Short Term Use of NSAID With Anticoagulant Ill Advised
Even Short Term Use of NSAID With Anticoagulant Ill Advised

(HealthDay News) -- Use of nonsteroidal anti-inflammatories (NSAIDs) may raise the risk for myocardial infarction (MI), stroke, and/or serious bleeding among MI survivors taking prescription anticoagulants, with no safe window period, according to new research. Bleeding risk rose even within the first three days of NSAID use, the team noted in a study published in the Feb. 24 issue of the Journal of the American Medical Association.

A team led by Anne-Marie Schjerning Olsen, M.D., of Copenhagen University Hospital in Denmark, examined NSAID use among 61,971 Danish patients who survived a first MI between 2002 and 2011. All were 30 and older (average age, 68 years), and all had survived at least a month after hospital discharge. More than six in 10 were men. Danish national hospital records revealed that all were on some form of anticoagulant treatment, such as aspirin or clopidogrel, following their MI.

During a follow-up period of about 3.5 years, 30 percent were rehospitalized as a result of another MI, stroke, or similar cardiac event. Almost 10 percent suffered bleeding -- in the head, respiratory tract, urinary tract, and/or gastrointestinal tract. And 30 percent died during the follow-up. Investigators noted that more than one-third were taking at least one NSAID alongside their anticoagulant. And they determined that doing so -- no matter what type of NSAID or anticoagulant they were on -- significantly bumped up the risk for serious complications and/or death.

"I would absolutely minimize your NSAID use if you're a patient in this category," Charles Campbell, M.D., chief of cardiovascular medicine at the University of Tennessee Erlanger Health Systems in Chattanooga and coauthor of an accompanying editorial, told HealthDay.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »